Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eukaryot Cell ; 6(11): 1979-91, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17873083

ABSTRACT

Translational control mediated by phosphorylation of the alpha subunit of the eukaryotic initiation factor 2 (eIF2alpha) is central to stress-induced programs of gene expression. Trypanosomatids, important human pathogens, display differentiation processes elicited by contact with the distinct physiological milieu found in their insect vectors and mammalian hosts, likely representing stress situations. Trypanosoma brucei, the agent of African trypanosomiasis, encodes three potential eIF2alpha kinases (TbeIF2K1 to -K3). We show here that TbeIF2K2 is a transmembrane glycoprotein expressed both in procyclic and in bloodstream forms. The catalytic domain of TbeIF2K2 phosphorylates yeast and mammalian eIF2alpha at Ser51. It also phosphorylates the highly unusual form of eIF2alpha found in trypanosomatids specifically at residue Thr169 that corresponds to Ser51 in other eukaryotes. T. brucei eIF2alpha, however, is not a substrate for GCN2 or PKR in vitro. The putative regulatory domain of TbeIF2K2 does not share any sequence similarity with known eIF2alpha kinases. In both procyclic and bloodstream forms TbeIF2K2 is mainly localized in the membrane of the flagellar pocket, an organelle that is the exclusive site of exo- and endocytosis in these parasites. It can also be detected in endocytic compartments but not in lysosomes, suggesting that it is recycled between endosomes and the flagellar pocket. TbeIF2K2 location suggests a relevance in sensing protein or nutrient transport in T. brucei, an organism that relies heavily on posttranscriptional regulatory mechanisms to control gene expression in different environmental conditions. This is the first membrane-associated eIF2alpha kinase described in unicellular eukaryotes.


Subject(s)
Cell Membrane/enzymology , Flagella/enzymology , Trypanosoma brucei brucei/cytology , Trypanosoma brucei brucei/enzymology , eIF-2 Kinase/metabolism , Amino Acid Sequence , Animals , Endosomes/enzymology , Eukaryotic Initiation Factor-2/metabolism , Glycosylation , Humans , Intracellular Membranes/enzymology , Life Cycle Stages , Mammals , Molecular Sequence Data , Phosphorylation , Phosphothreonine/metabolism , Protein Structure, Tertiary , Protein Transport , Protozoan Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Trypanosoma brucei brucei/growth & development , eIF-2 Kinase/chemistry
2.
Biochem J ; 367(Pt 2): 359-68, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12137565

ABSTRACT

The heterotrimeric eukaryotic initiation factor (eIF) 2 binds the initiator methionyl-tRNA in a GTP-dependent mode and delivers it to the 40 S ribosomal subunit. In the present study, we have identified amino acid residues in eIF2beta required for binding to eIF2gamma in yeast. Alteration of six residues in the central region of eIF2beta abolished this interaction, as determined by GST-pull down and two-hybrid assays, and leads to cell lethality. Substitution of (131)Tyr and (132)Ser by alanine residues ((131)YS), although abolishing the binding to eIF2gamma in these assays, resulted in a functional but defective protein in vivo, imparting a temperature-sensitive growth phenotype to cells. A dramatically weakened association of this mutant protein with eIF2gamma in vivo was shown by co-immunoprecipitation. The (131)YS mutation in eIF2beta allows translation to initiate at non-AUG codons, as defined by the ability of cells carrying an initiator codon mutation in the HIS4 mRNA to grow in the absence of histidine. The combination of this mutation with the (264)Ser-->Tyr alteration, a previously isolated suppressor of initiator codon mutations which has been shown to increase the spontaneous GTP hydrolysis in the ternary complex, caused a recessive lethality, suggesting additive defects. Thus the impaired interaction of these two subunits represents a novel type of defect in eIF2 function, providing in vivo evidence that the strength of interaction between eIF2beta and eIF2gamma defines the correct usage of the AUG codon for translation initiation.


Subject(s)
Codon, Initiator , Eukaryotic Initiation Factor-2/genetics , Eukaryotic Initiation Factor-2/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/genetics , Amino Acid Sequence , Amino Acid Substitution , Archaeal Proteins/genetics , Archaeal Proteins/metabolism , Base Sequence , Binding Sites , Conserved Sequence , Genes, Suppressor , Guanosine Triphosphate/metabolism , Hydrolysis , Molecular Sequence Data , Mutation , Protein Biosynthesis , Protein Subunits , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...